Mutational analysis of gene families in human cancer

被引：36

作者：

Bardelli, A ^{[1
]}

Velculescu, VE

机构：

[1] Univ Turin, Sch Med, Oncogenom Ctr, IRCCS, I-10060 Candiolo, Italy

[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA

来源：

CURRENT OPINION IN GENETICS & DEVELOPMENT | 2005年 / 15卷 / 01期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.gde.2004.12.009

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The completion of the human genome project has marked a new beginning in biomedical sciences. Human cancer is a genetic disease and, accordingly, the field of oncology has been one of the first to be impacted by this historic revolution. Knowledge of the sequence and organization of the human genome facilitates the systematic analysis of the genetic alterations underlying the origin and evolution of tumors. Recent mutational analyses in colorectal and other cancers have focused on examination of gene families involved in signal transduction, such as kinases and phosphatases. This approach has been successful in identifying mutations in a variety of different genes, including the identification of P13KCA as one of the most commonly mutated oncogenes in human cancer. Such genomic analyses have already demonstrated their utility in basic and clinical cancer research, and are expected to have an important impact on future diagnostic and therapeutic strategies.

引用

页码：5 / 12

页数：8

共 46 条

[11] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

[12] The ins and outs of signalling [J].

Downward, J .

NATURE, 2001, 411 (6839) :759-762

[13] Imatinib as a paradigm of targeted therapies [J].

Druker, BJ .

ADVANCES IN CANCER RESEARCH, VOL 91, 2004, 91 :1-+

[14] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[15] Hidden Markov models [J].

Eddy, SR .

CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (03) :361-365

[16] Phosphoregulators: Protein kinases and protein phosphatases of mouse [J].

Forrest, ARR ;

Ravasi, T ;

Taylor, D ;

Huber, T ;

Hume, DA ;

Grimmond, S .

GENOME RESEARCH, 2003, 13 (6B) :1443-1454

[17] A census of human cancer genes [J].

Futreal, PA ;

Coin, L ;

Marshall, M ;

Down, T ;

Hubbard, T ;

Wooster, R ;

Rahman, N ;

Stratton, MR .

NATURE REVIEWS CANCER, 2004, 4 (03) :177-183

[18] Opinion - Integrated global profiling of cancer [J].

Hanash, S .

NATURE REVIEWS CANCER, 2004, 4 (08) :638-644

[19]

Hunter T, 1998, Harvey Lect, V94, P81

[20] The conformational plasticity of protein kinases [J].

Huse, M ;

Kuriyan, J .

CELL, 2002, 109 (03) :275-282

← 1 2 3 4 5 →